Your browser doesn't support javascript.
loading
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
Arzu Yasar, H; Turna, Hande; Esin, Ece; Murat Sedef, A; Alkan, Ali; Oksuzoglu, Berna; Ozdemir, Nuriye; Sendur, Ma Nahit; Sezer, Ahmet; Kilickap, Saadettin; Utkan, Gungor; Akbulut, Hakan; Celik, Ismail; Abali, Huseyin; Urun, Yuksel.
Afiliação
  • Arzu Yasar H; Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
  • Turna H; Medical Oncology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey.
  • Esin E; Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Murat Sedef A; Medical Oncology, Baskent University Adana Hospital, Adana, Turkey.
  • Alkan A; Medical Oncology, Osmaniye State Hospital, Osmaniye, Turkey.
  • Oksuzoglu B; Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Ozdemir N; Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey.
  • Sendur MN; Medical Oncology, Faculty of Medicine, Ankara Atatürk Education and Research Hospital, Yildirim Beyazit University, Ankara, Turkey.
  • Sezer A; Medical Oncology, Baskent University Adana Hospital, Adana, Turkey.
  • Kilickap S; Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Utkan G; Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
  • Akbulut H; Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
  • Celik I; Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Abali H; Medical Oncology, Acibadem Mehmet Ali Aydinlar University School of Medicine, Istanbul, Turkey.
  • Urun Y; Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
J Oncol Pharm Pract ; 26(2): 267-272, 2020 Mar.
Article em En | MEDLINE | ID: mdl-30924738

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uveais / Ipilimumab / Antineoplásicos Imunológicos / Melanoma / Mucosa Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uveais / Ipilimumab / Antineoplásicos Imunológicos / Melanoma / Mucosa Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article